Shyam Aravamudhan

Prof. Shyam Aravamudhan

Joint School of Nanoscience and Nanoengineering, North Carolina A&T State University, Greensboro, NC 27401, USA
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MBMehrnoosh Bahadorani
Mehrnoosh Bahadorani
MNMahboobeh Nasiri
Mahboobeh Nasiri
KDKristen Dellinger
Kristen Dellinger
Shyam AravamudhanShyam Aravamudhan
Shyam Aravamudhan
RZReza Zadegan
Reza Zadegan
Exosomes emerge from endosomal invagination and range in size from 30 to 200 nm. Exosomes contain diverse proteins, lipids, and nucleic acids, which can indicate the state of various physiological and pathological processes. Studies have revealed the remarkable clinical potential of exosomes in diagnosing and prognosing multiple diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions. Exosomes also have the potential to be engineered and deliver their cargo to a specific target. However, further advancements are imperative to optimize exosomes’ diagnostic and therapeutic capabilities for practical implementation in clinical settings. This review highlights exosomes’ diagnostic and therapeutic applications, emphasizing their engineering through simple incubation, biological, and click chemistry techniques. Additionally, the loading of therapeutic agents onto exosomes, utilizing passive and active strategies, and exploring hybrid and artificial exosomes are discussed.

23 February 2024 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MHMoha Feroz Hossen
Moha Feroz Hossen
SSSachin M Shendokar
Sachin M Shendokar
Shyam AravamudhanShyam Aravamudhan
Shyam Aravamudhan
As layered materials, transition metal dichalcogenides (TMDCs) are promising two-dimensional (2D) materials. Interestingly, the characteristics of these materials are transformed from bulk to monolayer. The atomically thin TMDC materials can be a good alternative to group III–V and graphene because of their emerging tunable electrical, optical, and magnetic properties. Although 2D monolayers from natural TMDC materials exhibit the purest form, they have intrinsic defects that limit their application. However, the synthesis of TMDC materials using the existing fabrication tools and techniques is also not immune to defects. Additionally, it is difficult to synthesize wafer-scale TMDC materials for a multitude of factors influencing grain growth mechanisms. While defect engineering techniques may reduce the percentage of defects, the available methods have constraints for healing defects at the desired level. Thus, this holistic review of 2D TMDC materials encapsulates the fundamental structure of TMDC materials, including different types of defects, named zero-dimensional (0D), one-dimensional (1D), and two-dimensional (2D). Moreover, the existing defect engineering methods that relate to both formation of and reduction in defects have been discussed. Finally, an attempt has been made to correlate the impact of defects and the properties of these TMDC materials.

16 June 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
FAFrederick Aryeetey
Frederick Aryeetey
TITetyana Ignatova
Tetyana Ignatova
Shyam AravamudhanShyam Aravamudhan
Shyam Aravamudhan
We report on controllably creating and quantifying atomic defects with varying sulfur vacancies using helium ion irradiation in MoS 2 .

2 October 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
SSSheikh Saudi
Sheikh Saudi
SBShanta R. Bhattarai
Shanta R. Bhattarai
UAUdhab Adhikari
Udhab Adhikari
SKShalil Khanal
Shalil Khanal
JSJagannathan Sankar
Jagannathan Sankar
Narayan BhattaraiNarayan Bhattarai
Narayan Bhattarai
A drug-induced nanonet-nano fiber mesh of PCL–chitosan for high entrapment capacity and extended release of hydrophilic drugs.

25 September 2018 in Journal of Materials Research
Verified
Journal Article
Closed access
PDF file
SWSmith Woosley
Smith Woosley
NGNasim Abuali Galehdari
Nasim Abuali Galehdari
AKAjit Kelkar
Ajit Kelkar
Shyam AravamudhanShyam Aravamudhan
Shyam Aravamudhan

21 October 2019 in Catalysts
Verified
Journal Article
Open access
PDF file
NMNafeezuddin Mohammad
Nafeezuddin Mohammad
SBSujoy Bepari
Sujoy Bepari
Shyam AravamudhanShyam Aravamudhan
Shyam Aravamudhan
DKDebasish Kuila
Debasish Kuila
Fischer–Tropsch (FT) synthesis was carried out in a 3D printed stainless steel (SS) microchannel microreactor using bimetallic Co-Ru catalysts on three different mesoporous silica supports. CoRu-MCM-41, CoRu-SBA-15, and CoRu-KIT-6 were synthesized using a one-pot hydrothermal method and characterized by Brunner–Emmett–Teller (BET), temperature programmed reduction (TPR), SEM-EDX, TEM, and X-ray photoelectron spectroscopy (XPS) techniques. The mesoporous catalysts show the long-range ordered structure as supported by BET and low-angle XRD studies. The TPR profiles of metal oxides with H2 varied significantly depending on the support. These catalysts were coated inside the microchannels using polyvinyl alcohol and kinetic performance was evaluated at three different temperatures, in the low-temperature FT regime (210–270 °C), at different Weight Hourly Space Velocity (WHSV) in the range of 3.15–25.2 kgcat.h/kmol using a syngas ratio of H2/CO = 2. The mesoporous supports have a significant effect on the FT kinetics and stability of the catalyst. The kinetic models (FT-3, FT-6), based on the Langmuir–Hinshelwood mechanism, were found to be statistically and physically relevant for FT synthesis using CoRu-MCM-41 and CoRu-KIT-6. The kinetic model equation (FT-2), derived using Eley–Rideal mechanism, is found to be relevant for CoRu-SBA-15 in the SS microchannel microreactor. CoRu-KIT-6 was found to be 2.5 times more active than Co-Ru-MCM-41 and slightly more active than CoRu-SBA-15, based on activation energy calculations. CoRu-KIT-6 was ~3 and ~1.5 times more stable than CoRu-SBA-15 and CoRu-MCM-41, respectively, based on CO conversion in the deactivation studies.